UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031436
Receipt number R000035478
Scientific Title Influence of Water Soluble Silicon for Fatty Liver Combined with Lifestyle Related Disease
Date of disclosure of the study information 2018/02/23
Last modified on 2019/02/23 22:47:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Influence of Water Soluble Silicon for Fatty Liver Combined with Lifestyle Related Disease

Acronym

Effect of water-soluble silicon for fatty liver

Scientific Title

Influence of Water Soluble Silicon for Fatty Liver Combined with Lifestyle Related Disease

Scientific Title:Acronym

Effect of water-soluble silicon for fatty liver

Region

Japan


Condition

Condition

Lifestyle-related disease Combined fatty liver

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of water-soluble silicon in fatty liver combined with lifestyle-related disease.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes


Blood pressure measurement, physical measurement, general blood test, blood biochemical test, abdominal ultrasonography, fibrosis marker test, inflammatory marker test, oxidative stress type marker test, adipocytokine type marker test, questionnaire

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Single blind -participants are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Approximately 9 ml of water-soluble silicon is drunk for 6 months per day. Diet therapy is also done for drinking intake group.

Interventions/Control_2

For non-ingesting group, do not drink it but do only usual diet therapy.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who satisfy any of the following items are targeted.
1: outpatient with lifestyle-related disease
2: Patients complicated with metabolic syndrome
3: Patients complicated with nonmetabolic syndrome and judged as fatty liver by image diagnosis
4: Patients with fatty liver whose other liver injury was denied

Key exclusion criteria

Exclude any person who falls under any of the following.
1 Viral hepatitis and liver cirrhosis
2 serious liver dysfunction (liver function test value is more than 3 times normal upper limit)
3 heart failure
4 Severe ketosis or Diabetic coma Type 1 diabetes
5 severe renal dysfunction
6 Severe infection or Patients before and after surgery
7 Patients with a history of hypersensitivity to water-soluble silicon
8 Patients who may be pregnant or pregnant
9 Patients with metabolic liver disease
10 Patients with autoimmune liver disease
11 Patients with cirrhosis /due to causes other than 1
12 When the consent of the patient can not be obtained
13 Case in which the doctor approved inappropriate for participation in the study

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshitaka Fukuzawa

Organization

Aichi Medical University Hospital

Division name

Preemptive and Integrative Medicine Center

Zip code


Address

Karimata 1-1, Yazako, Nagakute city, Aichi Prefecture

TEL

0561-62-3311

Email

yofuku@aichi-med-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshitaka Fukuzawa

Organization

Aichi Medical University Hospital

Division name

Preemptive and Integrative Medicine Center

Zip code


Address

Karimata 1-1, Yazako, Nagakute City, Aichi Prefecture

TEL

0561-62-3311

Homepage URL


Email

yofuku@aichi-med-u.ac.jp


Sponsor or person

Institute

Aichi Medical University Hospital

Institute

Department

Personal name



Funding Source

Organization

Aichi Medical University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 02 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 02 Month 23 Day

Date of IRB


Anticipated trial start date

2018 Year 02 Month 23 Day

Last follow-up date

2019 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 02 Month 23 Day

Last modified on

2019 Year 02 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035478


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name